The world’s largest DNA sequencing company says it will form a new company to develop blood tests that cost $1,000 or less and can detect many types of cancer before symptoms arise.
Illumina, based in San Diego, said its blood tests should reach the market by 2019, and would be offered through doctors’ offices or possibly a network of testing centers.
{iframe}http://www.technologyreview.com/news/545326/illuminas-bid-to-beat-cancer-with-dna-tests/?utm_campaign=newsletters&utm_source=newsletter-daily-all&utm_medium=email&utm_content=20160111{/iframe}